Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

President Donald Trump has ordered the Department of Health and Human Services to standardize Medicare payments in an effort ...

The cause of death has been confirmed for Michelle Trachtenberg, the 39-year-old actress who was found dead in a New York ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial. Novartis ...

Presently, Merck only markets and sells one other oncology drug exclusively ... or 9% of revenues, diabetes segment that earned $2.3bn, or 4% of revenues, virology segment, $1.8bn, 2% of revenues ...

Merck MRK and AbbVie ABBV are leading pharmaceutical companies with strong portfolios in oncology and immunology. While ...

Merck already has the world’s biggest selling oral treatment for type 2 diabetes, its DPP-4-based drugs Januvia and Janumet, but it is playing catch-up in the SGLT2 market. The monotherapy and ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks ...

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...

Continue » The leader in diabetes and obesity Despite Lilly's huge success in treating diabetes and obesity, it's not the ...